Charles Sternberg, Associate Editor11.16.23
IlluminOss Medical, a medical device company focused on minimally invasive orthopedic fracture repair, is addressing an unmet need in the burgeoning senior population.
According to the National Osteoporosis Foundation, as many as 2 million Medicare recipients sustained roughly 2.3 million fractures related to osteoporosis in 2015.
Anthony M. Deluise Jr. MD FAAOS, CAQSH, explains, "In the case of a humerus fracture, many physicians previously would have said the best course of action is non-surgical, which could a sling and a year of immobility. If the patient is healthy enough for surgery, they would undergo an arduous procedure, with a long time under anesthesia and morphine during recovery with potential negative effects on memory. IlluminOss offers a minimally invasive approach for fracture repair and stabilization, with a return to normal activity within days."
Fragility fractures result in an enormous burden on the medical system in terms of hospitalization, subsequent rehabilitation, and potential complications.
The IlluminOss System utilizes a light-curable liquid monomer, contained within an expandable balloon, to create a patient-conforming, rigid implant within the bone canal. Surgeons report that their patients regain mobility faster and are able to resume their daily living activities far faster than conventional implants.
The IlluminOss technology has been in clinical use in Europe since 2010, and in the U.S. since 2018, with over 8,000 procedures to date. In the U.S., the IlluminOss System is now indicated for use in skeletally mature patients in the treatment of traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, ulna, clavicle, pelvis, fibula, metacarpals, metatarsals, and phalanges.
The IlluminOss Photodynamic Bone Stabilization System can also be used in conjunction with FDA-cleared fracture fixation systems to provide supplemental fixation in these anatomic sites. The IlluminOss System may be used in the femur and tibia to provide supplemental fixation to an anatomically appropriate FDA-cleared fracture fixation system.
According to the National Osteoporosis Foundation, as many as 2 million Medicare recipients sustained roughly 2.3 million fractures related to osteoporosis in 2015.
Anthony M. Deluise Jr. MD FAAOS, CAQSH, explains, "In the case of a humerus fracture, many physicians previously would have said the best course of action is non-surgical, which could a sling and a year of immobility. If the patient is healthy enough for surgery, they would undergo an arduous procedure, with a long time under anesthesia and morphine during recovery with potential negative effects on memory. IlluminOss offers a minimally invasive approach for fracture repair and stabilization, with a return to normal activity within days."
Fragility fractures result in an enormous burden on the medical system in terms of hospitalization, subsequent rehabilitation, and potential complications.
The IlluminOss System utilizes a light-curable liquid monomer, contained within an expandable balloon, to create a patient-conforming, rigid implant within the bone canal. Surgeons report that their patients regain mobility faster and are able to resume their daily living activities far faster than conventional implants.
The IlluminOss technology has been in clinical use in Europe since 2010, and in the U.S. since 2018, with over 8,000 procedures to date. In the U.S., the IlluminOss System is now indicated for use in skeletally mature patients in the treatment of traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, ulna, clavicle, pelvis, fibula, metacarpals, metatarsals, and phalanges.
The IlluminOss Photodynamic Bone Stabilization System can also be used in conjunction with FDA-cleared fracture fixation systems to provide supplemental fixation in these anatomic sites. The IlluminOss System may be used in the femur and tibia to provide supplemental fixation to an anatomically appropriate FDA-cleared fracture fixation system.